Legend Biotech (LEGN) EV to EBIT (2020 - 2026)

Legend Biotech (LEGN) EV to EBIT (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to EBIT
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 232,854.65
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -41,251.84
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 604.41
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 25.48
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn 10,112.54
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 15.49
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 43.12
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 49.30
9 Revolution Medicines 37.15 Bn 37.15 Bn - -84.03
10 Legend Biotech 11.04 Bn 10.14 Bn 242.10 Mn 18.04

Historic Data

Download Data
DateValue
Jul 17, 2026 -25.98
Jul 16, 2026 -26.57
Jul 15, 2026 -27.00
Jul 14, 2026 -30.45
Jul 13, 2026 -30.55
Jul 10, 2026 -32.30
Jul 9, 2026 -32.69
Jul 8, 2026 -33.33
Jul 7, 2026 -33.08
Jul 6, 2026 -33.56
Jul 2, 2026 -36.01
Jul 1, 2026 -35.98
Jun 30, 2026 -34.66
Jun 29, 2026 -35.33
Jun 26, 2026 -34.41
Jun 26, 2026 -34.41
Jun 25, 2026 -34.07
Jun 24, 2026 -35.31
Jun 23, 2026 -35.21
Jun 22, 2026 -35.26